Oxygenta Pharmaceutical Ltd — Others, 25-08-2025: Others

Oxygenta Pharmaceutical's board has approved the reclassification of four promoter group shareholders, holding a combined 9,42,700 shares, to public shareholders, pending necessary approvals. The board also noted the resignations of Mr. Vankineni Sai Sudhakar as Managing Director and CFO, and Mr. Sanagari Kondal Reddy as Independent Director, both due to a change in company ownership. New compositions for the Audit and Nomination and Remuneration Committees were approved. The company has also scheduled its Annual General Meeting for the financial year 2024-25 and approved related reports.